Skip to main content
. 2016 Apr 8;11(4):e0150806. doi: 10.1371/journal.pone.0150806

Table 1. Baseline Characteristics of the Study Cohort Stratified by Statin Therapy.

Characteristics Total NO (%) Statin Therapy NO (%) No Statin Therapy NO(%) P value
All eligible patients 14,958 11,268(75.3) 3690(24.7) <0.001
Demographic
 Age, years 0.092
  <55 3346(22.4) 2563(22.7) 783(21.2)
  55–64 3562(23.8) 2710(24.1) 852(23.1)
  65–74 4471(29.8) 3258(28.9) 1213(32.9)
  ≥75 3579(23.9) 2737(24.3) 842(22.8)
 Gender
  Female 4446(29.7) 3306(29.3) 1140(30.9) 0.073
CVD risk factors
 Prior hypertension 7430(49.7) 5908(52.4) 1522(41.2) <0.001
 Prior diabetes 2603(17.4) 2134(18.9) 469(12.7) <0.001
 Prior dyslipidemia 9050(60.5) 7410(65.8) 1640(44.4) <0.001
 Current smoker 5242(35.0) 4197(37.2) 1045(28.3) <0.001
Medical histories
 Myocardial infarction 1615(10.8) 1267(11.2) 348(9.4) 0.002
 Ischemic stroke 1534(10.3) 1159(10.3) 375(10.2) 0.831
 Hemorrhagic stroke 184(1.2) 134(1.2) 50(1.4) 0.428
Clinical characteristics at admission
 Chest discomfort 13751(91.9) 10467(92.9) 3284(89.0) <0.001
 Cardiac arrest 176(1.2) 141(1.3) 35(0.9) 0.138
 Cardiac shock 644(4.3) 462(4.1) 182(4.9) 0.031
AMI type
 STEMI 12806(85.6) 9569(84.9) 3237(87.7) <0.001
Laboratory test
 LDL-C level, mmol/L <0.001
  < 1.81 1443(9.6) 1158(10.3) 285(7.7)
  1.81–2.59 3677(24.6) 3030(26.9) 647(17.5)
  2.60–3.37 3803(25.4) 3166(28.1) 637(17.3)
  >3.37 2707(18.1) 2291(20.3) 416(11.3)
  Unmeasured 3328(22.2) 1623(14.4) 1705(46.2)
Economic-geographic region <0.001
 Eastern 8866(59.3) 6783(60.2) 2083(56.4)
 Central 3195(21.4) 2246(19.9) 949(25.7)
 Western 2897(19.4) 2239(19.9) 658(17.8)
Urban/Rural
 Rural 5664(37.9) 3796(33.7) 1868(50.6) <0.001
 Urban 9294(62.1) 7472(66.3) 1822(49.4)
Year <0.001
 2001 2198(14.7) 613(5.4) 1585(43.0)
 2006 4159(27.8) 3016(26.8) 1143(31.0)
 2011 8601(57.5) 7639(67.8) 962(26.1)

AMI indicates acute myocardial infarction;

STEMI indicates ST-segment elevation myocardial infarction;

LDL-C indicates low density lipid cholesterol.